Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer

Journal:
The New England Journal of Medicine
Published:
DOI:
10.1056/nejmoa2511218
Affiliations:
29
Authors:
39
Go to article
Institutions Authors Share
Pfizer, United States of America (USA)
5.000000
 0.13
Alliance Foundation Trials (AFT), United States of America (USA)
4.500000
 0.12
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
3.000000
 0.08
Mayo Clinic, United States of America (USA)
2.500000
 0.06
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA)
2.000000
 0.05
Yale University, United States of America (USA)
2.000000
 0.05
Molecular Predictors and New Targets in Oncology, France
2.000000
 0.05
Peter MacCallum Cancer Centre (Peter Mac), Australia
1.500000
 0.04
The University of Melbourne (UniMelb), Australia
1.500000
 0.04
UNC Lineberger Comprehensive Cancer Center, United States of America (USA)
1.000000
 0.03
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
 0.03
Indiana University Indianapolis (IU Indianapolis), United States of America (USA)
1.000000
 0.03
German Breast Group GmbH (GBG), Germany
1.000000
 0.03
Garvan Institute of Medical Research, Australia
1.000000
 0.03
Centre Léon Bérard (CLB), France
1.000000
 0.03
University of Pennsylvania (Penn), United States of America (USA)
1.000000
 0.03
Hospital Universitario 12 de Octubre, Spain
1.000000
 0.03
Kliniken Essen-Mitte, Germany
1.000000
 0.03
Hospital Clinic of Barcelona, Spain
1.000000
 0.03
Health New Zealand Auckland, New Zealand
1.000000
 0.03
Fondazione Michelangelo, Italy
1.000000
 0.03
Vall d'Hebron University Hospital (HUVH), ICS, Spain
1.000000
 0.03
Instituto Oncologico Dr. Rosell, Spain
0.500000
 0.01
Dexeus University Hospital, Spain
0.500000
 0.01
Saint Antoine Research Center (CRSA), France
0.333333
 0.01
Institut Universitaire de Cancérologie (IUC), France
0.333333
 0.01
UNICANCER Group, France
0.333333
 0.01
Interested in Oncology and Carcinogenesis?